Streetbeat News

Stock Prices

AZPN

Aspen Technology (NASDAQ:AZPN) has received indifferent ratings from four analysts in the last quarter. The average 12-month price target for the company is $179.75, representing a 9.45% decrease from the previous average price target of $198.50.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 12:03 pm

VNOM

Analysts have provided bullish ratings for Viper Energy Partners (NASDAQ:VNOM) within the last quarter, with an average price target of $37.4, implying an upside from the current price of $28.185. This represents a 5.08% decrease from the previous average price target of $39.40.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 12:03 pm

MNRO

Monro's CEO and President, Michael T Broderick, has purchased 10,000 shares of the company at an average price of $35.03 per share, according to a Form 4 filing.

Portfolio Pulse from Happy Mohamed

August 04, 2023 | 12:03 pm

RMNI

Rimini Street (NASDAQ:RMNI) reported Q2 earnings of $0.10 per share, missing the analyst consensus estimate of $0.12 by 16.67%. However, the company's quarterly sales of $106.42 million beat the analyst consensus estimate of $105.20 million by 1.16%. This represents a 42.86% increase in earnings and a 5.16% increase in sales compared to the same period last year.

Portfolio Pulse from saritha@benzinga.com

August 04, 2023 | 12:03 pm

BRSH

Shares of Bruush Oral Care were halted on a circuit breaker to the upside, with the stock now up 1.6%.

Portfolio Pulse from Happy Mohamed

August 04, 2023 | 12:03 pm

BA

Boeing's shares are trading lower due to overall market weakness following Fitch's downgrade of the U.S. long-term credit rating.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 12:03 pm

BIIB

A significant amount of unusual options activity has been observed for Biogen (NASDAQ:BIIB), with a mix of bullish and bearish stances. The trades have targeted a price range from $190.0 to $320.0 for Biogen over the last 3 months. The current price of BIIB is $270.34, up 0.39%. Several financial institutions have maintained their positive ratings on Biogen, with price targets ranging from $320 to $355.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 12:03 pm

KVUE

A significant amount of unusual options activity has been detected for Kenvue (NYSE:KVUE), with a bearish stance being taken by a whale investor. Of the 35 strange trades detected, 45% were bullish and 54% were bearish. The total amount for puts was $1,531,398 and for calls was $775,940. Whales have been targeting a price range from $15.0 to $40.0 for Kenvue over the last 3 months.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 12:03 pm

IVOL

JMBS

KBE

USO

Small-cap ETFs, Janus Henderson Mortgage-Backed Securities ETF (JMBS) and Quadratic Interest Rate Volatility & Inflation Hedge ETF (IVOL), have seen an increase in net assets over the past week, adding $199.23 million and $178.59 million respectively. On the other hand, SPDR S&P Bank ETF (KBE) and The United States Oil Fund LP (USO) have lost $82.79 million and $71.68 million in net assets respectively.

Portfolio Pulse from Johnny Rice

August 04, 2023 | 12:03 pm

JPM

JPMorgan Chase & Co's CEO, Jamie Dimon, has stated that despite the looming economic storm clouds, there is no need to worry as the economy is in good shape. He highlighted the resilience of America, the strength of the consumer, and the good condition of businesses. However, he expressed concern over fiscal spending, quantitative tightening, and the crisis in Ukraine. JPMorgan shares are up more than 15% since the start of the year, but were down 1.21% at $155.26 at the time of writing.

Portfolio Pulse from Adam Eckert

August 04, 2023 | 12:02 pm